Alexian Brothers Behavioral Health Hospital

Hoffman Estates, Illinois 60194

0 studies enrolling now · 10 studies all time

What they study most

Binge Eating Disorder, Cognitive Dysfunction, Cognitive Impairment Associated With Schizophrenia, Major Depressive Disorder, Negative Symptoms, Schizophrenia

Studies at this site

• SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder — Completed
• A Study to Evaluate the Safety and Efficacy of TS-121 as an Adjunctive Treatment for Major Depressive Disorder — Stopped early
• Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients — Completed
• An Inpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Treatment Of Acute Exacerbation Of Schizophrenia — Completed
• Treatment-Resistant Depression Registry — Completed
• Efficacy, Safety, and Tolerability of TC-5619 as Augmentation Therapy to Improve Negative Symptoms and Cognition in Outpatients With Schizophrenia — Completed
• Safety and Tolerability Study of Drug to Treat Schizophrenia — Completed
• A Comparison of Study Drug With Placebo and Haloperidol in Patients With Schizophrenia — Completed
• Safety and Efficacy of Study Drug Versus Placebo for Negative Symptoms of Schizophrenia — Completed
• Study to Evaluate the Safety and Efficacy of MEM 3454 as Adjunctive Treatment in Combination With a Preexisting Antipsychotic in Patients With Cognitive Impairment Associated With Schizophrenia — Status unconfirmed